Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Sarcoma 1

Conditions

Uterine Cervical Neoplasms 74Prostatic Neoplasms 54Breast Neoplasms 15Neoplasms 11Sarcoma 10Endometrial Neoplasms 10Vaginal Neoplasms 8Esophageal Neoplasms 6Uterine Neoplasms 5Radiation Injuries 5Lung Neoplasms 5Liver Neoplasms 5Vulvar Neoplasms 4Glioblastoma 4Carcinoma, Ductal, Breast 4Adenocarcinoma 4Retinoblastoma 3Ovarian Neoplasms 3Neuroectodermal Tumors, Primitive, Peripheral 3Hyperthermia 3Gliosarcoma 3Desmoplastic Small Round Cell Tumor 3Central Nervous System Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Carcinoma, Hepatocellular 3Breast Carcinoma In Situ 3Brain Neoplasms 3Uveal Melanoma 2Rhabdomyosarcoma 2Rectal Neoplasms 2

Interventions

Radiotherapy 3Radiation 3Paclitaxel 3Cisplatin 3Taxes 2Carboplatin 2Brachytherapy 2Standard of Care 1Practice Guidelines as Topic 1Platinum 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Endometrial Clear Cell Adenocarcinoma × Brachytherapy × Clear all
NCT03422198 2025-12-12

SAVE

University of Utah

Phase 3 Recruiting
188 enrolled 15 charts
GynecologicSarcoma

Endometrial Clear Cell Adenocarcinoma

NCT00942357 2021-10-19

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer

GOG Foundation

Phase 3 Unknown
813 enrolled 14 charts
Gynecologic

Endometrial Clear Cell Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡